Spravato

What Is Spravato?

Spravato is an FDA-approved, clinician-administered nasal medication used for treatment-resistant depression.

It is typically recommended for individuals who:

• Have not responded to multiple antidepressant medications
• Experience severe depressive episodes
• Struggle with persistent suicidal thoughts

Spravato is administered in-office under medical supervision. Patients are monitored following administration to ensure safety and stabilization.

Integrated Treatment Approach

Spravato is often used in combination with oral antidepressants and psychotherapy.

For individuals with complex or recurrent depression, Spravato can be part of a broader treatment plan that may also include TMS, neurofeedback, medication management, and trauma-focused therapy.